Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

P. Szaflarski, Jerzy; Martina Bebin, Elizabeth; M. Comi, Anne; D. Patel, Anup; Joshi, Charuta; Checketts, Daniel; C. Beal, Jules; C. Laux, Linda; M. De Boer, Lisa; H. Wong, Matthew; Lopez, Merrick; Devinsky, Orrin; D. Lyons, Paul; Pichon Zentil, Pilar; Wechsler, Robert; EAP study group, CBD

doi:10.1111/epi.14477

Public

Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

Shared by NobleBlocks on Jul 12, 2018 • 12:00 AM UTC

Authors:

Jerzy P. Szaflarski

Elizabeth Martina Bebin

Anne M. Comi

Abstract

Summary Objective Since 2014, cannabidiol ( CBD ) has been administered to patients with treatment‐resistant epilepsies ( TREs ) in an ongoing expanded‐access program ( EAP ). We report interim results on the safety and efficacy of CBD in EAP patients treated through December 2016. Methods Twenty‐fi...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!